Background information about HZI
How do bacteria and viruses make us sick? How does our immune system defend our body? Which novel pharmaceutical compounds can help us to fight dangerous infections? These are questions we at the HZI want to answer. Our goal: To set up the basis for new diagnostic tools, new drugs and new therapies against infectious diseases.
In 2022, the Helmholtz Centre for Infection Research had a budget amounting to about 93 million euros which is provided by the Federal Republic of Germany and the States of Lower Saxony, Bavaria, Saarland and Mecklenburg-Vorpommern through the programme-oriented funding (POF) of the Helmholtz Association.
Additionally, leaders of research groups and departments acquire third-party funding from national research funding programmes, EU programmes and private industry, which in total amounted to 38,4 million euros in 2022.
Furthermore, the HZI is responsible for the funding management for the German Center for Infection Research (DZIF).
Patents und Publications
In many cases, research results are registered as patents. Currently, HZI holds 76 patent families – numbers of patent groups dating from one original application – in total. Moreover, HZI can lay claim to a total of 661 publications (2021) in international, high-ranking scientific magazines.
Employees and Professional sectors
The HZI currently employs 1012 employees (31.12.2022) from various professional sectors: biologists, biotechnologists, biochemists, chemists, physicians, laboratory workers and assistants, office personnel, animal-care technicians, network specialists, craftsmen, technicians and engineers. They represent more than 30 different nationalities.
Currently around 150 guest scientists and guest doctoral students work at the HZI.